Shares of TherapeuticsMD slid 7.09% to $1.57 at 14:50 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is sliding 1.65% to $13,309.70, following last session’s downward trend, This seems, at the moment, an all-around rough trend exchanging session today.
TherapeuticsMD’s last close was $1.69, 75.16% below its 52-week high of $2.75.
TherapeuticsMD’s Sales
TherapeuticsMD’s sales growth is 37.7% for the ongoing quarter and 55.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 47.4% and 52.4%, respectively.
TherapeuticsMD’s Revenue
Year-on-year quarterly revenue growth declined by 18.5%, now sitting on 58.2M for the twelve trailing months.
Volatility
TherapeuticsMD’s last day, last week, and last month’s average volatility was 4.73%, 2.96%, and 5.89%, respectively.
TherapeuticsMD’s last day, last week, and last month’s high and low average amplitude percentage was 10.30%, 9.54%, and 12.15%, respectively.
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $1.57 at 14:50 EST, way under its 52-week high of $2.75 and way above its 52-week low of $0.85.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s value is below its 50-day moving average of $1.64 and above its 200-day moving average of $1.47.
